Investigator Development Core
研究者开发核心
基本信息
- 批准号:10357586
- 负责人:
- 金额:$ 40.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-06-15 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressBehavioral ResearchBiomedical ResearchClimateClinical ResearchClinical Trials UnitCountryDataDevelopmentEducational process of instructingEnsureEnvironmentExtramural ActivitiesFacultyFosteringFundingFunding OpportunitiesGenerationsGoalsGoldGrantGrowthHawaiiHealth Disparities ResearchHispanic PopulationsIncentivesIndividualInfrastructureInstitutionInvestmentsMalignant NeoplasmsMentorsMentorshipMexicoMinority Health ResearchMinority-Serving InstitutionMissionModelingNational Institute of General Medical SciencesOutcomePilot ProjectsPlayPopulationPostdoctoral FellowPreparationProcessReportingResearchResearch ActivityResearch PersonnelResourcesRoleScientistSecureSeedsServicesStructureStudentsThinkingTimeTrainingUnderrepresented MinorityUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesWritingcareercareer developmentfaculty researchhealth disparityimprovedinnovationinterestmemberminority health disparitynext generationprogramsrecruitresponsesoundsuccesssynergism
项目摘要
ABSTRACT
The BBRC RCMI proposes to create an Investigator Development Core (IDC), the purpose of which is to foster
excellence of BBRC RCMI investigators at all career stages, with a special focus on Early Stage Investigators
(ESI). The goals of the IDC will be to create a culture of mentorship, support and research excellence within the
BBRC RCMI, incentivize the submission of extramural grants by ESI, and to offer opportunities for BBRC RCMI
investigators to seek seed funding for pilot projects sponsored by the center. The innovative aspects of this
approach include (1) extending support to all BBRC RCMI investigators of any career stage; and (2) a “synergy
= success” model which incorporates the commitments of multiple stakeholders at the university, programmatic,
and external levels to ensure a sustained support of BBRC RCMI Investigators. Drawing from best practices and
lessons learned from fellow RCMIs that have identified and addressed key barriers to center success, the BBRC
RCMI proposes IDC activities to include: (1) mentorship of senior postdoctoral fellows and ESI, including
involvement of the NIGMS-funded National Research Mentoring Network (NRMN); (2) training on grant writing
for BBRC RCMI investigators; (3) course release offers to ESI in exchange for using the protected time to write
and submit proposals for extramural funding; (4) opportunities for ESI to compete for seed funds to jumpstart
efforts to secure preliminary data for preparation of larger competitive grant submissions; and (5) opportunities
for senior postdoctoral fellows and senior investigators to secure small-term starter or bridge funds, respectively,
at critical transition points in their research career. It is anticipated that the concerted investment of UTEP and
the BBRC RCMI at all levels of organization will succeed in creating a dynamic and productive workforce, sustain
a support structure throughout the career trajectories of early-, mid-, and senior-level investigators, and facilitate
the generation of outstanding research products that contribute to our understanding of minority health disparities
in the border region.
摘要
BBRC RCMI建议创建一个研究者发展核心(IDC),其目的是促进
BBRC RCMI调查员在所有职业阶段的卓越表现,特别关注早期调查员
(ESI)。国际数据中心的目标将是在全球范围内创造一种指导、支持和卓越研究的文化。
BBRC RCMI,鼓励ESI提交校外赠款,并为BBRC RCMI提供机会
研究人员寻求种子资金的试点项目由中心赞助。创新的方面,
方法包括(1)向所有处于职业生涯阶段的BBRC RCMI调查员提供支持;以及(2)“协同作用
=成功”的模式,其中包括在大学的多个利益攸关方的承诺,方案,
和外部层面,以确保BBRC RCMI调查员的持续支持。借鉴最佳做法,
从其他区域医疗机构中吸取的经验教训,这些经验教训已经确定并解决了中心成功的关键障碍,
RCMI建议IDC活动包括:(1)指导高级博士后研究员和ESI,包括
参与NIGMS资助的国家研究指导网络(NRMN);(2)关于赠款写作的培训
对于BBRC RCMI调查员;(3)向ESI提供课程发布机会,以换取使用受保护的时间撰写
并提交校外资金的建议;(4)ESI竞争种子基金的机会,以启动
努力获得初步数据,以准备更大规模的竞争性赠款申请;以及(5)机会
为高级博士后研究员和高级研究员分别获得小额启动或过渡资金,
在他们研究生涯的关键转折点。预计UTEP的一致投资和
BBRC RCMI将在各级组织成功地建立一支充满活力和生产力劳动力队伍,
为早期、中期和高级调查员的职业轨迹提供支持结构,并促进
产生优秀的研究产品,有助于我们了解少数民族的健康差距
在边境地区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marc B Cox其他文献
Marc B Cox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marc B Cox', 18)}}的其他基金
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
7895986 - 财政年份:2009
- 资助金额:
$ 40.06万 - 项目类别:
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
7672264 - 财政年份:2008
- 资助金额:
$ 40.06万 - 项目类别:
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
8138498 - 财政年份:2008
- 资助金额:
$ 40.06万 - 项目类别:
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
7498086 - 财政年份:2008
- 资助金额:
$ 40.06万 - 项目类别:
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
7901370 - 财政年份:2008
- 资助金额:
$ 40.06万 - 项目类别:
Functional Characterization of FKBP52 Interactions with Steroid Hormone Receptors
FKBP52 与类固醇激素受体相互作用的功能表征
- 批准号:
8325101 - 财政年份:2008
- 资助金额:
$ 40.06万 - 项目类别:
Physiological Roles of Receptor-Associated Immunophilins
受体相关亲免素的生理作用
- 批准号:
7015565 - 财政年份:2005
- 资助金额:
$ 40.06万 - 项目类别:
Physiological Roles of Receptor-Associated Immunophilins
受体相关亲免素的生理作用
- 批准号:
6835062 - 财政年份:2005
- 资助金额:
$ 40.06万 - 项目类别:
Physiological Roles of Receptor-Associated Immunophilins
受体相关亲免素的生理作用
- 批准号:
7166079 - 财政年份:2005
- 资助金额:
$ 40.06万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 40.06万 - 项目类别:
Research Grant